Articles

Businesses would have to give workers rest breaks, shade and water under new Biden rule

The Biden administration plans to set the first-ever federal standards for handling excessive heat in the workplace.

I’m 73 and have $930,000 in my IRA. Should I wait for the market to go down before I do a Roth conversion?

Trying to time with the market is usually a fool’s errand, but there are several schools of thought about how to best do a conversion.

Annovis Bio’s stock rockets 119% after reporting positive data in Parkinson’s disease trial

The stock is on track for its best performance since May 21, 2021, when it gained 127%.

Novo Nordisk, Eli Lilly singled out by Biden, Sanders over drug prices

Shares of Novo Nordisk and Eli Lilly & Co. dropped early Tuesday after President Joe Biden and Sen. Bernie Sanders took aim at obesity and diabetes drug prices in a USA Today opinion piece.

If your mother had Alzheimer’s, your chances of getting it are higher

If your mother had Alzheimer’s disease at any age, your chances of getting it are higher, according to a recent study in JAMA Neurology.

FTC votes unanimously to block Tempur Sealy’s proposed $4 billion takeover of Mattress Firm

Deal documents show company wants to “kneecap competitors and dominate the market,” one Federal Trade Commission official says.

How did older households react to inflation?

Preserving consumption in the short-term means less resources for the future

Lennar’s stock dives below key chart level after longtime bull cuts rating

Lennar’s stock got chopped down Tuesday after a Raymond James analyst backed away from his longtime bullish call on the home builder — citing margin concerns and other company-specific “overhangs.”

Tens of millions of people are watching videos of home buyers sitting in empty houses

It costs a lot more to buy a house today than it did just a few years ago. And that expense starts with the down payment.

Is it possible to get a 5% mortgage rate? Yes, but here’s the catch.

Mortgage rates are hovering just below 7%, but there are ways for home buyers to get much lower rates.

This cheap biotech offers investors a play on ALS if trial data continues to impress

NeuroSense Therapeutics Ltd.’s stock rose 6.5% Tuesday, as analysts cheered data from the biotech’s late-stage trial of a treatment for the fatal disease amyotrophic lateral sclerosis, or ALS.

Why Adobe and Uber are newly named top stock picks at Deutsche Bank

Adobe is having success in AI and Uber is having success with its membership program.
1 1,341 1,342 1,343 1,344 1,345 2,645